Clinical trial
Comparison of Efficacy and Safety of Albumin Versus Fresh Frozen Plasma in Managing Diuretic Resistant Edema in Children With Idiopathic Nephrotic Syndrome
NCT07685093 is registered in ClinicalTrials.gov with Qamar Shafiq as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparison of Efficacy and Safety of Albumin Versus Fresh Frozen Plasma in Managing Diuretic Resistant Edema in Children With Idiopathic Nephrotic Syndrome
- Lead sponsor
- Qamar Shafiq
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- July 5, 2026
- Completion date
- October 17, 2026
- Enrollment
- 56 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
idiopathic nephrotic syndrome (ins)